Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines

Cell Growth and Differentiation

Volumn 9, Issue 11, 1998, Pages 897-903

  Kovalev, Sergey ^a   Marchenko, Natalia ^a   Swendeman, Steve ^b   LaQuaglia, Michael ^b   Moll, Ute M ^a,c  

^a STONY BROOK UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN P53; PROTEIN P73; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CHROMOSOME 1P; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

EID: 0031766420     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Leilas, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819, 1997.
2. Jost, C. A., Marin, M. C., and Kaelin, W. G., Jr. p73 is a human p53-related protein that can induce apoptosis. Nature (Lond.), 389: 191-194, 1997.
3. Schmale, H., and Bamberger, C. A novel protein with strong homology to the tumor suppressor p53. Oncogene, 15: 1363-1367, 1997.
4. Schwab, M., Praml, C., and Amler, L. C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer, 16: 211-229, 1996.
5. Takeda, O., Homma, C., Maseki, N., Sakurai, M., Kanda, N., Schwab, M., Nakamura, Y., and Kaneko, Y. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer, 10: 30-39, 1994.
6. Schleiermacher, G., Peter, M., Michon, J., Hugot, J. P., Vielh, P., Zucker, J. M., Magdelenat, H., Thomas, G., and Delattre, O. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer, 10: 275-281, 1994.
7. Caron, H., van Sluis, P., van Hoeve, M., de Kraker, J., Bras, J., Slater, R., Mannens, M., Voute, P. A., Westerveld, A., and Versteeg, R. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat. Genet., 4: 187-190, 1993.
8. Caron, H., Peter, M., van Sluis, P., Speleman, F., de Kraker, J., Laureys, G., Michon, J., Brugieres, L., Voute, P. A., Westerveld, A., et al. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum. Mol. Genet., 4: 535-539, 1995.
9. Versteeg, R., Caron, H., Cheng, N. C., van der Drift, P., Slater, R., Westerveld, A., Voute, P. A., Delattre, O., Laureys, G., Van Roy, N., et al. 1p36: every subband a suppressor? Eur. J. Cancer, 31A: 538-541, 1995.
10. Cheng, J. M., Hiemstra, J. L., Schneider, S. S., Naumova, A., Cheung, N. K., Cohn, S. L., Diller, L., Sapienza, C., and Brodeur, G. M. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Nat. Genet., 4: 191-194, 1993.
11. Martinsson, T., Sjoberg, R. M., Hedborg, F., and Kogner, P. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res., 55: 5681-5686, 1995.
12. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T., and Takahashi, T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58: 1380-1383, 1998.
13. Mai, M., Yokomizo, A., Qian, C. P., Yang, P., Tindall, D. J., Smith, D. I., and Liu, W. G. Activation of p73 silent allele in lung cancer. Cancer Res., 58: 2347-2349, 1998.
14. Cheng, N. C., Van Roy, N., Chan, A., Beitsma, M., Westerveld, A., Speleman, F., and Versteeg, R. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene, 10: 291-297, 1995.
15. Cheng, N. C., Chan, A. J., Beitsma, M. M., Speleman, F., Westerveld, A., and Versteeg, R. A human modifier of methylation for class I HLA genes (MEMO-1) maps to chromosomal bands 1p35-36.1. Hum. Mol. Genet., 5: 309-317, 1996.
16. Ciccarone, V., Spengler, B. A., Meyers, M. B., Biedler, J. L., and Ross, R. A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res., 49: 219-225, 1989.
17. Sugimoto, T., Kato, T., Sawada, T., Horii, Y., Kemshead, J. T., Hino, T., Morioka, H., and Hosoi, H. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. Cancer Res., 48: 2531-2537, 1988.
18. Barrois, M., Duarte, N., Dubourg, C., Terrier-Lacombe, M-J., Chompret, A., Kaghad, M., Hartmann, O., Caput, D., and Benard, J. Genomic and expression status of p73 gene in neuroblastoma patients. 8th Symposium on Advances in Neuroblastoma Research, Bath, United Kingdom, 1998.
19. Zhang, X., Benoit, E., Tsao, H., Majewski, P., and Haluska, F. G. Expression of the p73 gene in melanoma cell lines. Proc. Am. Assoc. Cancer Res., 39: 549, 1998.
20. Takahashi, H., lchimiya, S., Nimura, Y., Watanabe, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S., and Nakagawara, A. Mutation, allelo-typing and transcription analysis of the p73 gene in prostatic carcinoma. Cancer Res., 58: 2076-2077, 1998.
21. Prabhu, N. S., Somasundaram, K., Satyamoorthy, K., Herlyn, M., and Eldeiry, W. S. P73-β, unlike p53, suppresses growild typeh and induces apoptosis of human papillomavirus E6-expressing cancer cells. Int. J. Oncol., 13: 5-9, 1998.
22. Shvarts, A., Bazuine, M., Dekker, P., Ramos, Y. F., Steegenga, W. T., Merckx, G., van Ham, R. C., van der Houven van Oordt, W., van der Eb, A. J., and Jochemsen, A. G. Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics, 43: 34-42, 1997.
23. Clurman, B., and Groudine, M. Tumour-suppressor genes. Killer in search of a motive? Nature (Lond.), 389: 122-123, 1997.
24. Chelly, J., Montarras, D., Pinset, C., Berwald-Netter, Y., Kaplan, J. C., and Kahn, A. Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells. Eur. J. Biochem., 187: 691-698, 1990.
25. Chelly, J., and Kahn, A. In: K. B. Mullis, F. Ferre, and R. A. Gibbs (eds.), The Polymerase Chain Reaction. Boston: Birkhauser, 1994.
26. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M., and Ikawa, S. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med., 4: 839-843, 1998.
27. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dötsch, V., Andrews, N. C., Caput, D., and McKeon, F. p63, a p53 homolog at 3q 27-29, encodes multiple products with trans-activating, death-inducing, and dominant-negative activities. Mol. Cell., 2: 305-316, 1998.